instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'PRAVASTATIN SODIUM'? | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | 10MG/DAY | DrugDosageText | CC BY-NC-ND | 33716254 | 19,137,817 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | Recovered | ReactionOutcome | CC BY-NC-ND | 33716254 | 19,140,109 | 2021 |
What was the outcome of reaction 'Hypoglycaemia'? | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | Recovered | ReactionOutcome | CC BY-NC-ND | 33716254 | 19,137,817 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Pheochromocytoma Diagnosed during the Treatment of Diffuse Alveolar Hemorrhage, a Diagnostic Necessity before Using High-dose Glucocorticoids.
A 46-year-old woman with exacerbating hemoptysis and dyspnea was diagnosed with diffuse alveolar hemorrhage (DAH). High doses of glucocorticoids were initiated, but afterward, p... | CLOTIAZEPAM, CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE, PREDNISOLONE, TELMISARTAN | DrugsGivenReaction | CC BY-NC-ND | 33716288 | 19,913,035 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pheochromocytoma Diagnosed during the Treatment of Diffuse Alveolar Hemorrhage, a Diagnostic Necessity before Using High-dose Glucocorticoids.
A 46-year-old woman with exacerbating hemoptysis and dyspnea was diagnosed with diffuse alveolar hemorrhage (DAH). High doses of glucocorticoids were initiated, but afterward, p... | CLOTIAZEPAM, CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE, TELMISARTAN | DrugsGivenReaction | CC BY-NC-ND | 33716288 | 19,945,054 | 2021-09-01 |
What is the weight of the patient? | Pheochromocytoma Diagnosed during the Treatment of Diffuse Alveolar Hemorrhage, a Diagnostic Necessity before Using High-dose Glucocorticoids.
A 46-year-old woman with exacerbating hemoptysis and dyspnea was diagnosed with diffuse alveolar hemorrhage (DAH). High doses of glucocorticoids were initiated, but afterward, p... | 62.8 kg. | Weight | CC BY-NC-ND | 33716288 | 19,945,054 | 2021-09-01 |
What was the outcome of reaction 'Catecholamine crisis'? | Pheochromocytoma Diagnosed during the Treatment of Diffuse Alveolar Hemorrhage, a Diagnostic Necessity before Using High-dose Glucocorticoids.
A 46-year-old woman with exacerbating hemoptysis and dyspnea was diagnosed with diffuse alveolar hemorrhage (DAH). High doses of glucocorticoids were initiated, but afterward, p... | Recovering | ReactionOutcome | CC BY-NC-ND | 33716288 | 19,945,054 | 2021-09-01 |
What was the outcome of reaction 'Hypertension'? | Pheochromocytoma Diagnosed during the Treatment of Diffuse Alveolar Hemorrhage, a Diagnostic Necessity before Using High-dose Glucocorticoids.
A 46-year-old woman with exacerbating hemoptysis and dyspnea was diagnosed with diffuse alveolar hemorrhage (DAH). High doses of glucocorticoids were initiated, but afterward, p... | Recovering | ReactionOutcome | CC BY-NC-ND | 33716288 | 19,913,035 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Florid Interstitial Hemorrhages: A Novel Feature of Amoxicillin-Clavulanate-Induced Acute Tubulointerstitial Nephritis.
BACKGROUND Acute tubulointerstitial nephritis is most often induced by drug therapy and is characterized by the presence of edema, inflammatory infiltrates, and sometimes granulomas within the interst... | AMOXICILLIN\CLAVULANIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33716294 | 19,154,527 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tubulointerstitial nephritis'. | Florid Interstitial Hemorrhages: A Novel Feature of Amoxicillin-Clavulanate-Induced Acute Tubulointerstitial Nephritis.
BACKGROUND Acute tubulointerstitial nephritis is most often induced by drug therapy and is characterized by the presence of edema, inflammatory infiltrates, and sometimes granulomas within the interst... | AMOXICILLIN\CLAVULANIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33716294 | 19,154,527 | 2021-03-15 |
What was the outcome of reaction 'Tubulointerstitial nephritis'? | Florid Interstitial Hemorrhages: A Novel Feature of Amoxicillin-Clavulanate-Induced Acute Tubulointerstitial Nephritis.
BACKGROUND Acute tubulointerstitial nephritis is most often induced by drug therapy and is characterized by the presence of edema, inflammatory infiltrates, and sometimes granulomas within the interst... | Recovering | ReactionOutcome | CC BY-NC-ND | 33716294 | 19,154,527 | 2021-03-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | CARFILZOMIB, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 33716516 | 19,971,940 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | BORTEZOMIB, CARFILZOMIB, CISPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, LENALIDOMIDE, MELPHALAN, POMALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33716516 | 19,065,425 | 2021 |
What was the administration route of drug 'LENALIDOMIDE'? | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | Oral | DrugAdministrationRoute | CC BY-NC | 33716516 | 19,065,425 | 2021 |
What was the administration route of drug 'POMALIDOMIDE'? | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | Oral | DrugAdministrationRoute | CC BY-NC | 33716516 | 19,065,425 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | AS PART OF RVD-PACE, KVD AND KPD REGIMEN | DrugDosageText | CC BY-NC | 33716516 | 19,963,391 | 2021 |
What was the dosage of drug 'MELPHALAN'? | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | 200 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 33716516 | 20,010,918 | 2021 |
What was the outcome of reaction 'Disease progression'? | Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor s... | Fatal | ReactionOutcome | CC BY-NC | 33716516 | 19,971,940 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Akathisia'. | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | TETRABENAZINE | DrugsGivenReaction | CC BY | 33716922 | 19,975,465 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | TETRABENAZINE | DrugsGivenReaction | CC BY | 33716922 | 19,975,765 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dystonia'. | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | TETRABENAZINE | DrugsGivenReaction | CC BY | 33716922 | 19,975,765 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle rigidity'. | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | TETRABENAZINE | DrugsGivenReaction | CC BY | 33716922 | 19,975,767 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parkinsonism'. | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | TETRABENAZINE | DrugsGivenReaction | CC BY | 33716922 | 19,975,767 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | TETRABENAZINE | DrugsGivenReaction | CC BY | 33716922 | 19,975,767 | 2021 |
What was the administration route of drug 'TETRABENAZINE'? | A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.
Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cer... | Oral | DrugAdministrationRoute | CC BY | 33716922 | 19,975,767 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion induced'. | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, HYDROXYCHLOROQUINE, IMMUNE GLOBULIN NOS, LORATADINE, METHYLPREDNISOLONE, OXYGEN | DrugsGivenReaction | CC BY | 33717138 | 19,108,899 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, HYDROXYCHLOROQUINE, IMMUNE GLOBULIN NOS, LORATADINE, METHYLPREDNISOLONE, OXYGEN | DrugsGivenReaction | CC BY | 33717138 | 19,108,899 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, HYDROXYCHLOROQUINE, IMMUNE GLOBULIN NOS, LORATADINE, METHYLPREDNISOLONE, OXYGEN | DrugsGivenReaction | CC BY | 33717138 | 19,108,899 | 2021 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33717138 | 19,108,899 | 2021 |
What was the administration route of drug 'CYCLOSPORINE'? | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | Oral | DrugAdministrationRoute | CC BY | 33717138 | 19,108,899 | 2021 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33717138 | 19,108,899 | 2021 |
What was the administration route of drug 'LORATADINE'? | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | Oral | DrugAdministrationRoute | CC BY | 33717138 | 19,108,899 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | Oral | DrugAdministrationRoute | CC BY | 33717138 | 19,108,899 | 2021 |
What was the administration route of drug 'OXYGEN'? | Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
Dermatomyositis occurs extremely rarely during pregnancy. A number of studies in the published literature have documented how the outcome of pregnancy ... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33717138 | 19,108,899 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | A case of Dressler's syndrome successfully treated with colchicine and acetaminophen.
The incidence of Dressler's syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary int... | APIXABAN, ASPIRIN, PRASUGREL | DrugsGivenReaction | CC BY-NC-ND | 33717379 | 19,096,678 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dressler^s syndrome'. | A case of Dressler's syndrome successfully treated with colchicine and acetaminophen.
The incidence of Dressler's syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary int... | APIXABAN, ASPIRIN, CLOPIDOGREL BISULFATE, PRASUGREL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33717379 | 18,606,016 | 2021-03 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | A case of Dressler's syndrome successfully treated with colchicine and acetaminophen.
The incidence of Dressler's syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary int... | 75MG/DAY | DrugDosageText | CC BY-NC-ND | 33717379 | 18,606,016 | 2021-03 |
What was the dosage of drug 'PRASUGREL HYDROCHLORIDE'? | A case of Dressler's syndrome successfully treated with colchicine and acetaminophen.
The incidence of Dressler's syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary int... | 3.75MG/DAY | DrugDosageText | CC BY-NC-ND | 33717379 | 18,606,016 | 2021-03 |
What was the dosage of drug 'PRASUGREL'? | A case of Dressler's syndrome successfully treated with colchicine and acetaminophen.
The incidence of Dressler's syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary int... | 3.75 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33717379 | 19,096,678 | 2021-03 |
What was the outcome of reaction 'Dressler^s syndrome'? | A case of Dressler's syndrome successfully treated with colchicine and acetaminophen.
The incidence of Dressler's syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary int... | Recovered | ReactionOutcome | CC BY-NC-ND | 33717379 | 18,606,016 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour lysis syndrome'. | A rare cause of acute liver failure due to haemophagocytic lymphohistiocytosis secondary to diffuse large B-cell lymphoma.
Acute liver failure is a life-threatening condition commonly caused by drug-induced hepatotoxicity or viral hepatitides. However, there are a number of rarer causes such as haemophagocytic lymphohi... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33717491 | 19,225,049 | 2021-03 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | A rare cause of acute liver failure due to haemophagocytic lymphohistiocytosis secondary to diffuse large B-cell lymphoma.
Acute liver failure is a life-threatening condition commonly caused by drug-induced hepatotoxicity or viral hepatitides. However, there are a number of rarer causes such as haemophagocytic lymphohi... | 1 g (grams). | DrugDosage | CC BY-NC | 33717491 | 19,225,049 | 2021-03 |
What was the outcome of reaction 'Tumour lysis syndrome'? | A rare cause of acute liver failure due to haemophagocytic lymphohistiocytosis secondary to diffuse large B-cell lymphoma.
Acute liver failure is a life-threatening condition commonly caused by drug-induced hepatotoxicity or viral hepatitides. However, there are a number of rarer causes such as haemophagocytic lymphohi... | Not recovered | ReactionOutcome | CC BY-NC | 33717491 | 19,225,049 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | GEMCITABINE\GEMCITABINE HYDROCHLORIDE, PACLITAXEL | DrugsGivenReaction | CC BY | 33717763 | 19,089,437 | 2021-02-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atypical haemolytic uraemic syndrome'. | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | GEMCITABINE\GEMCITABINE HYDROCHLORIDE, PACLITAXEL | DrugsGivenReaction | CC BY | 33717763 | 19,089,437 | 2021-02-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | ECULIZUMAB | DrugsGivenReaction | CC BY | 33717763 | 19,046,622 | 2021-02-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | GEMCITABINE\GEMCITABINE HYDROCHLORIDE, PACLITAXEL | DrugsGivenReaction | CC BY | 33717763 | 19,089,437 | 2021-02-10 |
What was the administration route of drug 'ECULIZUMAB'? | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | Subcutaneous | DrugAdministrationRoute | CC BY | 33717763 | 19,046,622 | 2021-02-10 |
What was the administration route of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33717763 | 19,089,437 | 2021-02-10 |
What was the outcome of reaction 'General physical health deterioration'? | Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Atypical hemolytic uremic syndrome (aHUS) is an atypical type of thrombotic microangiopathy (TMA), which is characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and thrombi in small blood vessels, leading to end-organ da... | Fatal | ReactionOutcome | CC BY | 33717763 | 19,046,622 | 2021-02-10 |
What was the administration route of drug 'LINACLOTIDE'? | Pill to Pain: First Case of Topiramate-Induced Chronic Spontaneous Coronary Artery Dissection (SCAD).
Spontaneous coronary artery dissection (SCAD) is a non-traumatic, non-iatrogenic, and non-atherosclerotic coronary artery disorder that manifests clinically as acute coronary syndrome (ACS), arrhythmia, or sudden cardi... | Oral | DrugAdministrationRoute | CC BY | 33717765 | 19,089,312 | 2021-02-10 |
What was the dosage of drug 'ALBUTEROL'? | Pill to Pain: First Case of Topiramate-Induced Chronic Spontaneous Coronary Artery Dissection (SCAD).
Spontaneous coronary artery dissection (SCAD) is a non-traumatic, non-iatrogenic, and non-atherosclerotic coronary artery disorder that manifests clinically as acute coronary syndrome (ACS), arrhythmia, or sudden cardi... | TWO PUFFS EVERY FOUR HOURS AS NEEDED | DrugDosageText | CC BY | 33717765 | 19,089,312 | 2021-02-10 |
What was the dosage of drug 'ASPIRIN'? | Pill to Pain: First Case of Topiramate-Induced Chronic Spontaneous Coronary Artery Dissection (SCAD).
Spontaneous coronary artery dissection (SCAD) is a non-traumatic, non-iatrogenic, and non-atherosclerotic coronary artery disorder that manifests clinically as acute coronary syndrome (ACS), arrhythmia, or sudden cardi... | 81 mg (milligrams). | DrugDosage | CC BY | 33717765 | 19,089,312 | 2021-02-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory distress syndrome'. | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CICLESONIDE, FAVIPIRAVIR, HEPARIN SODIUM, INSULIN NOS, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CICLESONIDE, FAVIPIRAVIR, HEPARIN SODIUM, INSULIN NOS, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
What was the dosage of drug 'AZITHROMYCIN ANHYDROUS'? | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | 500 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
What was the dosage of drug 'CEFTRIAXONE'? | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | 1 g (grams). | DrugDosage | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
What was the dosage of drug 'CICLESONIDE'? | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | 800 µg (micrograms). | DrugDosage | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
What was the dosage of drug 'FAVIPIRAVIR'? | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | 1200 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
What was the dosage of drug 'REMDESIVIR'? | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | 200 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Usefulness of serial lung ultrasound for a severe COVID-19 patient on extracorporeal membrane oxygenation.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facili... | Recovered | ReactionOutcome | CC BY-NC-ND | 33717868 | 19,854,293 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.
Neoadjuvant therapy has significantly improved the 5-year overall survival (OS) of patients with resectable non-small cell lung cancer (NSCLC). The Ch... | CARBOPLATIN, NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33718040 | 19,803,636 | 2021-02 |
What was the dosage of drug 'CARBOPLATIN'? | Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.
Neoadjuvant therapy has significantly improved the 5-year overall survival (OS) of patients with resectable non-small cell lung cancer (NSCLC). The Ch... | UNK, CYCLIC (AUC=5, D1) | DrugDosageText | CC BY-NC-ND | 33718040 | 19,803,636 | 2021-02 |
What was the dosage of drug 'NIVOLUMAB'? | Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.
Neoadjuvant therapy has significantly improved the 5-year overall survival (OS) of patients with resectable non-small cell lung cancer (NSCLC). The Ch... | 360 MG, CYCLIC D1 | DrugDosageText | CC BY-NC-ND | 33718040 | 19,803,636 | 2021-02 |
What was the dosage of drug 'PACLITAXEL'? | Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.
Neoadjuvant therapy has significantly improved the 5-year overall survival (OS) of patients with resectable non-small cell lung cancer (NSCLC). The Ch... | 175 MG/M2, CYCLIC (D1) | DrugDosageText | CC BY-NC-ND | 33718040 | 19,803,636 | 2021-02 |
What was the administration route of drug 'CISPLATIN'? | Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin.
After more than four decades of post-approval, cisplatin is still an important treatment for numerous cancers. However, acute kidney injury (AKI), defined as significant impairment ... | Intraperitoneal | DrugAdministrationRoute | CC BY | 33718160 | 19,163,200 | 2021 |
What was the administration route of drug 'PACLITAXEL'? | Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin.
After more than four decades of post-approval, cisplatin is still an important treatment for numerous cancers. However, acute kidney injury (AKI), defined as significant impairment ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33718160 | 19,163,200 | 2021 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin.
After more than four decades of post-approval, cisplatin is still an important treatment for numerous cancers. However, acute kidney injury (AKI), defined as significant impairment ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33718160 | 19,163,200 | 2021 |
What was the outcome of reaction 'Hypomagnesaemia'? | Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin.
After more than four decades of post-approval, cisplatin is still an important treatment for numerous cancers. However, acute kidney injury (AKI), defined as significant impairment ... | Not recovered | ReactionOutcome | CC BY | 33718160 | 19,163,200 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver injury'. | Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.
Although cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland carcinoma (SGC), recurrence and metastases sometimes devel... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33718174 | 19,095,795 | 2021 |
What was the administration route of drug 'IPILIMUMAB'? | Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.
Although cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland carcinoma (SGC), recurrence and metastases sometimes devel... | Intravenous drip | DrugAdministrationRoute | CC BY | 33718174 | 19,095,795 | 2021 |
What was the administration route of drug 'NIVOLUMAB'? | Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.
Although cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland carcinoma (SGC), recurrence and metastases sometimes devel... | Intravenous drip | DrugAdministrationRoute | CC BY | 33718174 | 19,095,795 | 2021 |
What was the dosage of drug 'IPILIMUMAB'? | Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.
Although cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland carcinoma (SGC), recurrence and metastases sometimes devel... | 3 MILLIGRAM/KILOGRAM. SINGLE | DrugDosageText | CC BY | 33718174 | 19,095,795 | 2021 |
What was the dosage of drug 'NIVOLUMAB'? | Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.
Although cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland carcinoma (SGC), recurrence and metastases sometimes devel... | 80 MILLIGRAM, SINGLE | DrugDosageText | CC BY | 33718174 | 19,095,795 | 2021 |
What was the outcome of reaction 'Liver injury'? | Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.
Although cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland carcinoma (SGC), recurrence and metastases sometimes devel... | Recovering | ReactionOutcome | CC BY | 33718174 | 19,095,795 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute leukaemia'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'C-reactive protein increased'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device breakage'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile convulsion'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight gain poor'. | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | ACETAMINOPHEN, ALBUMIN HUMAN, AMPHOTERICIN B, BLINATUMOMAB, CILASTATIN SODIUM\IMIPENEM, CLONAZEPAM, CYCLOPHOSPHAMIDE, CYTARABINE, GEMTUZUMAB OZOGAMICIN, HUMAN IMMUNOGLOBULIN G, MERCAPTOPURINE, MEROPENEM, METHOTREXATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, PEGASPARGASE, PHLOROGLUCINOL, PIPERACILLI... | DrugsGivenReaction | CC BY | 33718232 | 19,058,055 | 2021 |
What is the weight of the patient? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 2.98 kg. | Weight | CC BY | 33718232 | 19,058,055 | 2021 |
What was the administration route of drug 'BLINATUMOMAB'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33718232 | 19,058,055 | 2021 |
What was the administration route of drug 'METHOTREXATE'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | Intrathecal | DrugAdministrationRoute | CC BY | 33718232 | 19,058,055 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | Intrathecal | DrugAdministrationRoute | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'ACETAMINOPHEN'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 1 DOSE/WEIGHT (7 KG) EVERY 6 HOURS | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'CLONAZEPAM'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 0.02 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'GEMTUZUMAB OZOGAMICIN'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 3 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 0.4 GRAM PER KILOGRAM | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE ACETATE'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 6 MILLIGRAM | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 6 MILLIGRAM | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'ONDANSETRON'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 2 MILLIGRAM, TWICE A DAY, AS NECESSARY | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'PEGASPARGASE'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 2500 IU INTERNATIONAL UNIT PER SQAURE METER | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'PHLOROGLUCINOL'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 1/4 TABLET, TWICE A DAY AS NECESSARY | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 60 MILLIGRAM/SQ. METER, QD | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'PROBIOTICS NOS'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 4 DROP, QD | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | 4 MILLILITER, TID | DrugDosageText | CC BY | 33718232 | 19,058,055 | 2021 |
What was the outcome of reaction 'Febrile convulsion'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | Recovered | ReactionOutcome | CC BY | 33718232 | 19,058,055 | 2021 |
What was the outcome of reaction 'Weight gain poor'? | Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure... | Recovered | ReactionOutcome | CC BY | 33718232 | 19,058,055 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.